Ibrutinib treatment alone showed >2 fold downregulation of survivin mRNA expression (Supplementary Figure 4C–4F), which was highly expressed in both primary tumors and EMC cell lines, when compared to control WT splenic B cells (Supplementary Figure 2D). Here, BIRC5 is linked to extraskeletal myxoid chondrosarcoma.